This article provides a descriptive account of the reports from the literature regarding the use of a combination of dexmedetomidine and ketamine for procedural sedation. Data Source: A ...

Koruk et al 17 Prospective randomized trial comparing dexmedetomidine–ketamine with midazolam-ketamine in 50 pediatric patients for extracorporeal shock wave lithotripsy Sedation was equally ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

According to the United States Drug Enforcement Administration (DEA), ketamine is a “dissociative anesthetic that has some hallucinogenic effects” and “can induce a state of sedation ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

One significant area of research has been the comparison of different sedation combinations. A meta-analysis examined the use of ketamine-dexmedetomidine (ketadex) versus ketamine-propofol ...

According to the United States Drug Enforcement Administration (DEA), ketamine is a "dissociative anesthetic that has some hallucinogenic effects" and "can induce a state of sedation, immobility ...

Drug Information and Alerts Aotearoa New Zealand (DIANZ) warns about vapes containing dangerous ‘space oil’. Etomidate vapes ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Side effects seen with IV and intranasal ketamine like dissociation, sedation, and increased blood pressure were also minimal, with the most common adverse reactions including dizziness and headache.